1.

Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof-of-concept clinical trial of new antivi...

2.

Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof-of-concept clinical trial of new antivi...

3.

Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof-of-concept clinical trial of new antivi...

4.

Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof-of-concept clinical trial of new antivi...

5.

Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof-of-concept clinical trial of new antivi...

1.

The use of chemotherapy regimens carrying a moderate or high risk of febrile neutropenia and the corresponding management of febrile neutropenia: an expert survey in breast cancer...

2.

The use of chemotherapy regimens carrying a moderate or high risk of febrile neutropenia and the corresponding management of febrile neutropenia: an expert survey in breast cancer...

3.

The use of chemotherapy regimens carrying a moderate or high risk of febrile neutropenia and the corresponding management of febrile neutropenia: an expert survey in breast cancer...

4.

The use of chemotherapy regimens carrying a moderate or high risk of febrile neutropenia and the corresponding management of febrile neutropenia: an expert survey in breast cancer...

5.

The use of chemotherapy regimens carrying a moderate or high risk of febrile neutropenia and the corresponding management of febrile neutropenia: an expert survey in breast cancer...

6.

The use of chemotherapy regimens carrying a moderate or high risk of febrile neutropenia and the corresponding management of febrile neutropenia: an expert survey in breast cancer...

7.

The use of chemotherapy regimens carrying a moderate or high risk of febrile neutropenia and the corresponding management of febrile neutropenia: an expert survey in breast cancer...

8.

The use of chemotherapy regimens carrying a moderate or high risk of febrile neutropenia and the corresponding management of febrile neutropenia: an expert survey in breast cancer...

1.

Psychometric properties of the emotion awareness questionnaire for children in a French-speaking population

2.

Psychometric properties of the emotion awareness questionnaire for children in a French-speaking population

3.

Psychometric properties of the emotion awareness questionnaire for children in a French-speaking population

4.

Psychometric properties of the emotion awareness questionnaire for children in a French-speaking population

5.

Psychometric properties of the emotion awareness questionnaire for children in a French-speaking population

1.

Can ill-structured problems reveal beliefs about medical knowledge and knowing? A focus-group approach.

2.

Can ill-structured problems reveal beliefs about medical knowledge and knowing? A focus-group approach.

3.

Can ill-structured problems reveal beliefs about medical knowledge and knowing? A focus-group approach.

4.

Can ill-structured problems reveal beliefs about medical knowledge and knowing? A focus-group approach.

5.

Can ill-structured problems reveal beliefs about medical knowledge and knowing? A focus-group approach.

1.

Diagnostic certainty, co-morbidity and medication in a primary care population with presumed airway obstruction : the DIDASCO2 study.

2.

Diagnostic certainty, co-morbidity and medication in a primary care population with presumed airway obstruction : the DIDASCO2 study.

3.

Diagnostic certainty, co-morbidity and medication in a primary care population with presumed airway obstruction : the DIDASCO2 study.

4.

Diagnostic certainty, co-morbidity and medication in a primary care population with presumed airway obstruction : the DIDASCO2 study.

5.

Diagnostic certainty, co-morbidity and medication in a primary care population with presumed airway obstruction : the DIDASCO2 study.

1.

Iron Overload in Polytransfused Patients without Heart Failure is Associated with Subclinical Alterations of Systolic Left Ventricular Function using Cardiovascular Magnetic Resona...

2.

Iron Overload in Polytransfused Patients without Heart Failure is Associated with Subclinical Alterations of Systolic Left Ventricular Function using Cardiovascular Magnetic Resona...

3.

Iron Overload in Polytransfused Patients without Heart Failure is Associated with Subclinical Alterations of Systolic Left Ventricular Function using Cardiovascular Magnetic Resona...

4.

Iron Overload in Polytransfused Patients without Heart Failure is Associated with Subclinical Alterations of Systolic Left Ventricular Function using Cardiovascular Magnetic Resona...

5.

Iron Overload in Polytransfused Patients without Heart Failure is Associated with Subclinical Alterations of Systolic Left Ventricular Function using Cardiovascular Magnetic Resona...

1.

Obesity: trend in inequality.

2.

Obesity: trend in inequality.

3.

Obesity: trend in inequality.

4.

Obesity: trend in inequality.

5.

Obesity: trend in inequality.

1.

The use of chemotherapy regimens carrying a moderate or high risk of febrile neutropenia and the corresponding management of febrile neutropenia : an expert survey in breast cancer...

2.

The use of chemotherapy regimens carrying a moderate or high risk of febrile neutropenia and the corresponding management of febrile neutropenia : an expert survey in breast cancer...

3.

The use of chemotherapy regimens carrying a moderate or high risk of febrile neutropenia and the corresponding management of febrile neutropenia : an expert survey in breast cancer...

4.

The use of chemotherapy regimens carrying a moderate or high risk of febrile neutropenia and the corresponding management of febrile neutropenia : an expert survey in breast cancer...

5.

The use of chemotherapy regimens carrying a moderate or high risk of febrile neutropenia and the corresponding management of febrile neutropenia : an expert survey in breast cancer...

1.

Equity in prevention and health care

2.

Equity in prevention and health care

3.

Equity in prevention and health care

4.

Equity in prevention and health care

5.

Equity in prevention and health care

6.

Equity in prevention and health care

7.

Equity in prevention and health care

8.

Equity in prevention and health care

1.

Internet: un moyen alternatif au présentiel pour la formation pédagogique de médecins isolés?